Value proposition

Find Answers. Take Action. #WeAreFMI

Foundation Medicine is a molecular information company dedicated to a transformation in cancer care in which treatment is informed by a deep understanding of the genomic changes that contribute to each patient's unique cancer. The company offers a full suite of comprehensive genomic profiling assays to identify the molecular alterations in a patient’s cancer and match them with relevant targeted therapies, immunotherapies and clinical trials. Foundation Medicine’s molecular information platform aims to improve day-to-day care for patients by serving the needs of clinicians, academic researchers and drug developers to help advance the science of molecular medicine in cancer.

For more information, please visit us at www.FoundationMedicine.com or follow @FoundationATCG on Twitter.

Community Guidelines: bit.ly/FMICommunityGuidelines

molecular information, cancer genomics, next-generation sequencing, precision medicine, comprehensive genomic profiling, and oncology